Knockdown of said lncRNA or upregulating miR-181a-5p, which is negatively correlated with ANRIL, may change that effect on colon cancer cells, resulting in radiosensitivity enhancement [44]. Here, CDKN2B-AS1 is linked to malignant colon neoplasm.